Tags

Type your tag names separated by a space and hit enter

Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis.
EBioMedicine. 2021 Sep; 71:103567.E

Links

Publisher Full Text
ncbi.nlm.nih.gov
linkinghub.elsevier.com
PMC Free PDF

Authors+Show Affiliations

Martin P
Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London W12 0HS, United Kingdom. Electronic address: paul.martin9@nhs.net.
Clarke C
Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London W12 0HS, United Kingdom; Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, United Kingdom.

MeSH

Antibodies, NeutralizingAntibodies, ViralCOVID-19COVID-19 VaccinesHumansRNA, MessengerRenal DialysisSARS-CoV-2Spike Glycoprotein, Coronavirus

Pub Type(s)

Journal Article

Language

eng

PubMed ID

34454401

Citation

Martin, Paul, and Candice Clarke. "Measuring Cellular and Humoral Immunogenicity of a SARS-CoV-2 mRNA Vaccine (BNT126b2) in Patients On Maintenance Haemodialysis." EBioMedicine, vol. 71, 2021, p. 103567.
Martin P, Clarke C. Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis. EBioMedicine. 2021;71:103567.
Martin, P., & Clarke, C. (2021). Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis. EBioMedicine, 71, 103567. https://doi.org/10.1016/j.ebiom.2021.103567
Martin P, Clarke C. Measuring Cellular and Humoral Immunogenicity of a SARS-CoV-2 mRNA Vaccine (BNT126b2) in Patients On Maintenance Haemodialysis. EBioMedicine. 2021;71:103567. PubMed PMID: 34454401.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis. AU - Martin,Paul, AU - Clarke,Candice, Y1 - 2021/08/26/ PY - 2021/08/17/received PY - 2021/08/17/accepted PY - 2021/8/29/pubmed PY - 2021/10/16/medline PY - 2021/8/28/entrez SP - 103567 EP - 103567 JF - EBioMedicine JO - EBioMedicine VL - 71 SN - 2352-3964 UR - https://www.unboundmedicine.com/medline/citation/34454401/Measuring_cellular_and_humoral_immunogenicity_of_a_SARS_CoV_2_mRNA_vaccine__BNT126b2__in_patients_on_maintenance_haemodialysis_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S2352-3964(21)00360-1 DB - PRIME DP - Unbound Medicine ER -